FIGURE

Fig. 2

ID

ZDB-FIG-180919-3

Publication

Zhang et al., 2018 - Monitoring antiangiogenesis of bevacizumab in zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Bevacizumab impairs formation of zebrafish SIV in a dose-dependent manner.
Representative fluorescent images of control or embryos treated with bevacizumab at 3 dpf. In control embryos, SIVs developed as a smooth basket-like structure over the yolk at 3 dpf (A, yellow dashed lines). In contrast, embryos treated with bevacizumab resulted in specific defects in SIVs formation (B, C, white dashed lines). (D, E) Quantification of the area and number of SIV show significant decrease in bevacizumab-treated embryos. Error bars, SEM; *P<0.0001 (n=10; ANOVA).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Drug Des Devel Ther